Hemophilia A Research Program (HARP) Education/ LinkedIn
Jul 22, 2026, 09:46
Clinical Trial Recruitment for the HARP Mother–Baby Study – HARP
Hemophilia A Research Program (HARP) Education shared a post on LinkedIn:
“The HARP mother-baby study in hemophilia is recruiting! Please help us get the word out!
Interested pregnant moms can go to HARP.
Providers can directly refer at: [email protected]
Flyers can also be downloaded at HARP Resources.
Hemophilia A Research Program (HARP) is looking to reach pregnant mothers anywhere in the U.S. Eligible moms have a genotype that causes hemophilia A (sometimes known as ‘carriers’) and a baby potentially at-risk for severe hemophilia A.
HARP is studying hemophilia bleeding risk in pregnancy and the causes of inhibitor formation in early childhood. To learn more visit HARP and Clinical Trials.”
Stay updated with Hemostasis Today.
-
Jul 22, 2026, 10:35Ifeanyichukwu Ifechidere: We’ve Trained an Entire Generation of Clinicians to Fear The Wrong Thing About HIT
-
Jul 22, 2026, 10:16Ney Carter Borges: Understanding Pathophysiology as the Foundation of Precision Cardiovascular Care
-
Jul 22, 2026, 10:01George Cieutat: Strengthening Connections Across the Bleeding Disorders Community
-
Jul 22, 2026, 09:57Ming Y Lim: Demonstrating the Value of Upfront Emicizumab at ISTH 2026
-
Jul 22, 2026, 09:52Danny Hsu: Get to Do Some Fun Stuff at ISTH 2026
-
Jul 22, 2026, 09:48Nita Radhakrishnan: The People Behind the Science at ISTH 2026
-
Jul 22, 2026, 09:41Shaymaa Alhabib: From My First PhD Poster to ISTH 2026
-
Jul 22, 2026, 09:35A Novel Peptide Strategy to Prevent Surface-Triggered Thrombosis – JTH
-
Jul 22, 2026, 09:29Alessandra Bosch: Presenting the Latest Evidence in Pediatric Anticoagulation at ISTH 2026